1 active not recruiting, 1 recruiting, 1 withdrawn. 1 Not applicable, 1 Phase 1, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Recruiting 1 |
| Phase 1 | 1 | Withdrawn 1 |
| Phase 2 | 1 | Withdrawn 1 |
| Phase 3 | 1 | Active not recruiting 1 |
Follow Stage II Fallopian Tube Cancer AJCC v8: new trials by email Literature Review of Stage II Fallopian Tube Cancer AJCC v8 trials Research Report on Stage II Fallopian Tube Cancer AJCC v8
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Automated Personalized Physical Activity Intervention to Improve Immune Function and Clinical Outcomes in Stage II-IV Ovarian, Primary Peritoneal or Fallopian Tube Cancer and Newly Diagnosed Endometrial Cancer, Life on the Go 3 Study Behavioral Intervention, Best Practice, Biospecimen Collection - Endometrial Carcinoma, Recurrent Fallopian Tube Carcinoma | Not applicable | Recruiting | Roswell Park Cancer Institute | 120 | 2025-06-04 | 2026-01-06 |
| Specialized Immune Cells (nCTLs) and a Vaccine (Alpha-type-1 Polarized Dendritic Cells) in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Alpha-type-1 Polarized Dendritic Cells, Autologous Natural Killer Cell-like CTLs - Stage II Fallopian Tube Cancer AJCC v8, Stage II Ovarian Cancer AJCC v8 | Phase 1 / Phase 2 | Withdrawn | Roswell Park Cancer Institute | 2023-12-15 | 2023-11-22 | |
| Letrozole With or Without Paclitaxel and Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Biopsy Procedure, Biospecimen Collection, Carboplatin - Low Grade Fallopian Tube Serous Adenocarcinoma, Ovarian Low Grade Serous Adenocarcinoma | Phase 3 | Active not recruiting | NRG Oncology | 450 | 2019-09-20 | 2026-03-24 |
Fallopian Tube Neoplasms (3) · Ovarian Neoplasms (3) · Endometrial Neoplasms (1)
Adnexal Diseases (3) · Endocrine Gland Neoplasms (3) · Endocrine System Diseases (3) · Fallopian Tube Diseases (3) · Female Urogenital Diseases (3) · Female Urogenital Diseases and Pregnancy Complications (3) · Genital Diseases (3) · Genital Diseases, Female (3) · Genital Neoplasms, Female (3) · Gonadal Disorders (3) · Neoplasms (3) · Neoplasms by Site (3) · Ovarian Diseases (3) · Urogenital Diseases (3) · Urogenital Neoplasms (3)
Specimen Handling (2) · Behavior Therapy (1) · Biopsy (1) · Carboplatin (1) · Letrozole (1) · Paclitaxel (1) · Palliative Care (1) · Practice Guidelines as Topic (1) · Standard of Care (1) · Taxes (1) · X-Rays (1)
Roswell Park Cancer Institute (2) · NRG Oncology (1)
United States (3) · Canada (1) · Ireland (1) · Peru (1) · Puerto Rico (1) · South Korea (1)
Amanda N Fader (1) · Emese Zsiros (1) · Emese Zsiros, MD, PhD (1)
P50CA159981 (2), U10CA180868 (1)